GENE ONLINE|News &
Opinion
Blog

Tau Protein
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
New Research Marks a Paradigm Shift in Countering Alzheimer’s Disease
2021-11-08
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Towards Exosome-Based Theranostics for Alzheimer’s Disease
2021-04-19
Biogen’s Alzheimer’s Drug Turned Down by Independent Panel
2020-11-07
Biogen Stocks Rise Following FDA’s Inspiriting Comments on Alzheimer’s Drug, Aducanumab
2020-11-05
UCB Joins Forces with Roche to Develop Antibody Treatment for Alzheimer’s
2020-07-31
LATEST
The Impact of “Inner Excellence” on A.J. Brown’s Performance and Mindset
2025-01-14
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Posdinemab Becomes J&J’s Second FDA Fast Track Designation Targeting Phosphorylated Tau in Alzheimer’s Disease
2025-01-09
Key Market Trends Shaping Health Systems and Specialty Pharmacies
2025-01-08
COVID Caused Cancer Tumors to Shrink in Mice and We Want to Know How
2025-01-08
Catapulting Stem Cell Research into the Future: Innovation and Global Impact at ISSCR 2025 in Hong Kong
2025-01-08
EVENT
2025-01-13
Biotech Showcase 2025
San Francisco, California
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
Scroll to Top